WebApr 30, 2024 · In the DAA era, despite 100% donor-derived HCV viremic rate among HCV-negative recipients, the original THINKER (Transplanting Hepatitis C kidneys Into Negative KidnEy Recipients) trials... WebJul 15, 2024 · Two recent, small clinical trials have assessed the feasibility of transplantation of kidneys from HCV-infected donors to HCV-negative recipients. 11 - 13 The Transplanting Hepatitis C Kidneys into Negative …
High multiplicity of infection following transplantation of hepatitis C …
WebJan 10, 2024 · January 10, 2024 The next stage of the THINKER project — THINKER-NEXT — is aiming to settle any lingering concerns that patients and centers might have about … WebNov 6, 2024 · HCV Therapy is Not Universally Accessible or Affordable Both clinical trials chose a 12-week regimen including elbasvir-grazoprevir, which has a listing price of $54,600. Patients were enrolled through two distinct investigator-initiated grants, so the cost of therapy was covered by the research protocol. norris rod failure analysis
New England Journal of Medicine
WebSep 14, 2024 · The opposite approach – transplant the HCV kidney then treat – explored in THINKER (Trial of Transplantation of HCV-Infected Kidneys Into Uninfected Recipients) led to complications, such... WebOct 17, 2024 · The THINKER trial was the first to evaluate the intentional transplantation of kidneys from HCV-viraemic donors to HCV-uninfected recipients and subsequent treatment with DAA therapy 8. WebA recent trial evaluated the use glecaprevir/pibrentasvir combined with ezetimibe 10 mg (as an inhibitor of HCV entry) in 30 recipients of nonhepatic organs (lung, heart, kidney) from … norris sanders wesson ms obituary